Enovix Corp ENVX
No buyback or stock pay figures in its 10-K data yet
XBRL, 10-KCash runway
Cash on the balance sheet of Oct 4, 2026 against the operating cash it used over the last four quarters · XBRL
Shown only when operating cash flow of the last twelve months is negative. A fact about the past twelve months, not a forecast: the company can raise money, cut costs or change pace. Debt due is on the Debt tab; share sales are in the dilution card below.
New shares against shares bought back
Dilution: new shares, stock pay and buybacks · S-3 and 424B, 3 years; 10-K
New Nov 2, 2026: Shelf registration: shares and other securities, amount not fixed (S-3) Email me when ENVX files the next one
Shares offered
Since Nov 17, 2023: 1 sale of new shares, 1 shelf registration; also 3 resales by holders.
- Nov 2, 2026 Shelf registration: shares and other securities, amount not fixed S-3
- Nov 1, 2024 Sale of 100.0M new shares ($100M) 424B5
Every offering filing“Under this shelf registration statement, we may, from time to time, offer and sell common stock and preferred stock, various series of debt securities and/or warrants to purchase any of such securities, either individually or in combination with other securities, in one or more offerings, up to a total dollar amount of $500,000,000 of any combination of the securities described in this prospectus.”
S-3, Nov 2, 2026
Paid in stock and bought back
No stock pay or buyback lines in the 10-K XBRL.
Where the cash came from and where it went
FY2025, from the cash flow statement in the 10-K, added up
The same cash, step by step
Came from
| Debt raised | $360.0M |
| Cash on hand used | $166.7M |
Went to
| Operating cash flow (outflow) | $95.3M |
| Capital spending | $18.2M |
| Buybacks | $58.4M |
| Other, net investments bought and sold, other financing and investing lines, and exchange rates |
$354.8M |
Each number is a line of the cash flow statement as the company tagged it. "Other, net" is what those lines do not cover (investments bought and sold, other financing and investing lines, and exchange rates); Tickdelta does not estimate it.
Where the operating cash went, year by year
FY2020 to FY2025 · cash flow statements, 10-K XBRL
| Fiscal year | Operating cash | Capital spending | Acquisitions | Buybacks | Debt repaid |
|---|---|---|---|---|---|
| Dec 28, 2025 | -$95.3M | $18.2M | - | $58.4M | - |
| Dec 29, 2024 | -$108.6M | $76.2M | - | - | $209K |
| Dec 31, 2023 | -$104.6M | $61.8M | $10.0M | - | $69K |
| Jan 1, 2023 | -$82.7M | $36.2M | - | $10K | - |
| Jan 2, 2022 | -$51.3M | $43.6M | - | $27K | $15.0M |
| Dec 31, 2020 | -$20.1M | $27.0M | - | - | - |
| Added up | -$462.7M | $263.0M | $10.0M | $58.4M | $15.3M |
Each bar is one fiscal year; its colours add up to what the cash flow statement says the company spent on each line, and the line across it is that year's operating cash flow. Spending above the line was paid from new debt, shares sold or cash on hand. A bar part links to the 10-K it comes from. A line the company did not report is left out, not estimated, so the shares are of operating cash only and can add up to more or less than 100%. Debt repaid is the gross amount, so refinanced debt is counted each time it is repaid. A reading aid, not a grade: Tickdelta does not say whether a split was good. Banks and insurers are left out.
Buybacks, dividends and share count
Year by year · XBRL, each 10-K
No buyback or share count data in the 10-K XBRL.
Buybacks month by month, and what is left to buy
Share buybacks · 10-Q, Part II Item 2, latest 4 quarters
“In June 2025, our Board of Directors approved a stock repurchase plan authorizing up to $60.0 million in common stock repurchases (the “Repurchase Plan”).”
10-Q, Part II Item 2
“In February 2026, our Board of Directors authorized the repurchase of up to $75.0 million worth of shares of the Company’s common stock, $0.0001 par value per share.”
10-Q, Part II Item 2
Spent each month (shares × average price)
| Month | Shares bought | Average price |
|---|---|---|
| Oct 2026 | 2,173,744 | $2.84 |
| Sep 2025 | 1,219,236 | $10.43 |
| Aug 2025 | 4,218,320 | $10.81 |
Shares and average price are the numbers in the 10-Q table, row by row; "shares × price" is our multiplication of the two. A row with a price of "-" is an accelerated repurchase paid up front, where the 10-Q does not give a price yet. A 10-Q that counts shares in millions gives a rounded number, shown as "about". Shares withheld for employees' taxes are not in this table. A month that no 10-Q table gives, or that this page could not read with confidence, is not shown.
What the 10-Ks show for each CEO's years
Each CEO's years · the CEO of each fiscal year as named in the proxy's pay versus performance table
Dr. Talluri
- Operating cash flow
- -$95.3M
- Capital spending
- $18.2M
- Buybacks
- $58.4M
- Stock-based pay
- $49.4M
- Diluted shares since FY2024
- +11.6%
- Revenue since FY2024
- +38%
- Debt since FY2024
- +$349.9M
- CEO pay (reported)
- $8.0M
Sources
The cash flow statement, dividends per share and diluted share count in each 10-K's XBRL; Part II Item 2 of each 10-Q for monthly buybacks; offering prospectuses (S-3, 424B) for new shares; Form D data sets for private raises.
Also
CEO pay: what the CEO was paid over the same years.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ENVX/export.csv") into a cell.